Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue California is a private, vertically integrated ingredient biotechnology company that develops and manufactures science-backed, nature-based ingredients for dietary supplements, functional foods and beverages, cosmetics, pet nutrition, and related consumer health markets. The company focuses on healthy aging, wellness, and delivery technologies, with commercial branded ingredients including ErgoActive ergothioneine, L-TeaActive l-theanine, Taxifolin BC-DHQ, hydroxytyrosol, CoQ10, vitamin K2, and fermentation-derived NMN. In addition to ingredient commercialization, Blue California offers microencapsulation through its FineCap platform and also supplies flavors and fragrances. Its business model is business-to-business rather than therapeutics-focused drug development, so its pipeline is best understood as a portfolio of commercial ingredients rather than clinical drug candidates. The company appears to be active and privately held, headquartered in Rancho Santa Margarita, California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue California.